HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral Administration of Poly-Gamma-Glutamic Acid Significantly Enhances the Antitumor Effect of HPV16 E7-Expressing Lactobacillus casei in a TC-1 Mouse Model.

Abstract
The conventional prophylactic vaccines for human papillomavirus (HPV) efficiently prevent infection with high-risk HPV types, but they do not promote therapeutic effects against cervical cancer. Previously, we developed HPV16 E7-expressing Lactobacillus casei (L. casei-E7) as a therapeutic vaccine candidate for cervical cancer, which induces antitumor therapeutic effects in a TC-1 murine cancer model. To improve the therapeutic effect of L. casei-E7, we performed co-treatment with poly-gamma-glutamic acid (γ-PGA), a safe and edible biomaterial naturally secreted by Bacillus subtilis. We investigated their synergistic effect to improve antitumor efficacy in a murine cancer model. The treatment with γ-PGA did not show in vitro cytotoxicity against TC-1 tumor cells; however, an enhanced innate immune response including activation of dendritic cells was observed. Mice co-administered with γ-PGA and L. casei-E7 showed significantly suppressed growth of TC-1 tumor cells and an increased survival rate in TC-1 mouse models compared to those of mice vaccinated with L. casei-E7 alone. The administration of γ-PGA markedly enhanced the activation of natural killer (NK) cells but did not increase the E7-specific cytolytic activity of CD8+ T lymphocytes in mice vaccinated with L. casei-E7. Overall, our results suggest that oral administration of γ-PGA induces a synergistic antitumor effect in combination with L. casei-E7.
AuthorsEunjin Kim, Jihyun Yang, Moon-Hee Sung, Haryoung Poo
JournalJournal of microbiology and biotechnology (J Microbiol Biotechnol) Vol. 29 Issue 9 Pg. 1444-1452 (Sep 28 2019) ISSN: 1738-8872 [Electronic] Korea (South)
PMID31387341 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Cancer Vaccines
  • Papillomavirus E7 Proteins
  • Papillomavirus Vaccines
  • oncogene protein E7, Human papillomavirus type 16
  • poly(gamma-glutamic acid)
  • Polyglutamic Acid
Topics
  • Adjuvants, Immunologic (administration & dosage, pharmacology)
  • Administration, Oral
  • Animals
  • Cancer Vaccines (administration & dosage, genetics, immunology)
  • Cell Survival
  • Cells, Cultured
  • Dendritic Cells (immunology)
  • Female
  • Immunity, Innate (drug effects)
  • Killer Cells, Natural (immunology)
  • Lacticaseibacillus casei (genetics)
  • Lymphocyte Activation (drug effects)
  • Mice
  • Mice, Inbred C57BL
  • Papillomavirus E7 Proteins (genetics, immunology)
  • Papillomavirus Vaccines (administration & dosage, genetics, immunology)
  • Polyglutamic Acid (administration & dosage, analogs & derivatives, pharmacology)
  • RAW 264.7 Cells
  • Uterine Cervical Neoplasms (prevention & control)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: